Celltrion
068270.KS
#794
Rank
A$41.79 B
Marketcap
A$191.04
Share price
0.00%
Change (1 day)
-2.96%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): A$2.88

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$2.70. In 2024 the company made an earnings per share (EPS) of A$1.91 a decrease over its 2023 EPS that were of A$3.79.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$2.8850.71%
2024A$1.91-49.57%
2023A$3.79-2.08%
2022A$3.87-11.72%
2021A$4.382.03%
2020A$4.3082.8%
2019A$2.3518.31%
2018A$1.99-36.33%
2017A$3.12161.25%
2016A$1.192.86%
2015A$1.1617.84%
2014A$0.995.87%
2013A$0.93-70.85%
2012A$3.19134.09%
2011A$1.3643.59%
2010A$0.9574.49%
2009A$0.54317.8%
2008A$0.13-71.7%
2007A$0.46